Introduction
As a target organ for toxicity the immune system is, at first glance, a logical choice to investigate. One could reason that prolonged exposure to a substance of low toxicity or an acute exposure to a highly toxic chemical may alter immunological functions and predispose an individual to increased disease susceptibility. In practice, however, documenting such effects is not the easy task one would hope for. This is due to the nature of the immune system, which comprises a large network of organs and varied cell types that carry out interrelated functions. Many of the cellular subpopulations are highly specialized, and there exist numerous avenues of communication and a complex regulatory network that governs responsiveness (1) . Of selective advantage to the host is the fact that the immune system offers several pathways for handling a challenge. This fact alone complicates toxicologic studies by allowing Cells of the immune system originate from a pluripotent stem cell pool found in the yolk sac and fetal liver during fetal development and in the bone marrow and spleen of the adult (2-4). As shown in Figure 1 , stem cells may follow one of several lines of maturation. Influential in the development of one major lymphocyte class is the thymus, which originates from the third and fourth pharyngeal pouches at 9 days of gestation in mice, (9 weeks in man). As stem cells pass through and are influenced by the thymus, they mature and acquire the characteristics of thymus-derived Tlymphocytes on their way into the peripheral lymphoid organs. Mature T-lymphocytes seed the thymic-dependent areas of the spleen and lymph nodes and comprise 55-74% of the peripheral blood lymphocytes (5, 6) . These cells can be distinguished from other lymphocytes by genetically defined alloantigenic cell surface markers: Thy 1 (theta) and Lyt 1, 2, and 3 (in mice), among others (7-9). Such cell surface markers provide handles with which to identify functional subpopulations of T-cells in normal and disease states. T-lymphocytes also respond to the mitogens phytohemagglutinin (PHA) and concanavalin A (con A), which can be used as a gross probe for the integrity of T-cell function (10, 11 example, patients with systemic lupus erythematosis have below normal suppressor T-cell function, resulting in unregulated antibody production (12) (13) (14) (15) (16) The pluripotent stem cell pool also contains the precursors of monocyte-macrophage and polymorphonuclear leukocyte (PMN) populations. The macrophage has an important role in genetically defined antigen-driven immune activation and tumor-cell killing in addition to its phagocytic role. Defects in stem cell differentiation into PMN's or macrophages will predispose the host to bacterial infection and in the case of a macrophage defect will February 1982 interrupt normal B-and T-lymphocyte activation.
As should be clear from the above discussion, toxicological alterations may affect the immune system in a very subtle or gross fashion depending upon the level of interference. If a single T-or B-cell subpopulation is affected, the loss of overall responsiveness and increase in disease susceptibility may be minimal. Such a loss of response may also be transient. However, an alteration in stem cell, thymus or bone marrow differentiative pathway may result in severe nonreversible impairment. It is important, therefore, to study a wide range of parameters in order accurately to assess any effect on the immune system as a whole.
Assessment of Immunologic Potential
Various immune assay systems measure different levels of cell involvement and complexity in response to a stimulus. As such, assays that measure responses that are a result of complex cell interaction mechanisms are more likely to reveal alterations in immune function. For this reason, one can order the immunologic parameters into a tier structure, based on sequential levels of cellular cooperation reflecting this degree of complexity. It is anticipated that studies of drug-or chemical-induced immune alterations would focus on the complex assay systems first. Once a druginduced lesion is found, the cause can be dissected using assays that involve less complex systems. Such an approach will ultimately lead to the assays that will pinpoint the cellular basis of dysfunction. Table 1 shows one possible tier structure. This tier system is not meant to be exhaustive but to serve as an example of one possible experimental design. The components of Tier I measure reactions that depend upon complex multicellular interactions involving T and B lymphocytes and macrophages. Genetically controlled regulatory networks play an important role in these responses. It would be anticipated that immune alterations at one of several sites in the cell interaction network would result in a modified response. However, since these systems are complex, it may be possible to compensate for an immune lesion by using an alternative response pathway. Furthermore, since these systems only assess a limited area of the total immune system several should be employed to provide good coverage.
The assay systems in Tier II involve cell interaction mechanisms that are less complex than those in Tier I, often inducing only M4-T-cell or B-cell-M4-suppressorT-cell interactions. These assay 5 
Conclusion
The immune response offers a well-defined system in which to study the toxic effects of suspected drugs or chemicals. Through many years of immunologic research our understanding of the complexity of the cellular interactions involved in any immune response allows us to ask specific toxicological questions. The following considerations are important in any immunotoxicological study. The immune system represents a complex multicellular, multiorgan network that may be affected at several sites. Alterations in one arm of the response (humoral or cellular) may not affect responses governed by the other limb. The immune system shows a great deal of resiliency and harmful effects may be transient. Some components of the immune system are long-lived (T-cells), whereas others are not (B-cells). Alterations in short-lived, replaceable systems may have little long-term consequence to the host. Immune response capability and the influence of various organs (thymus) changes with ages. Therefore deleterious effects may be a function of age. Since many immune responses are genetically controlled, alterations in responsiveness to one challenge in a given animal model may not hold true in second animal model. Genetic differences may also be seen between sexes.
In view of the above considerations it is important in any toxicological study of immune capacity to consider the immune system as a whole and design experimental protocols that consider the dynamic complexity of the system.
